Preprint
Article

This version is not peer-reviewed.

Cytostatic and Pro-Apoptotic Effects of Justicia spicigera Schltdl. on LNCaP Prostate Cancer Cells: Role of G0/G1 Cell Cycle Arrest and Phytochemical Characterization

Submitted:

21 January 2026

Posted:

22 January 2026

You are already at the latest version

Abstract
Justicia spicigera is a central medicinal plant in Mexican ethnomedicine, yet its therapeutic potential against prostate cancer remains largely unexplored. This study investigated the antiproliferative and pro-apoptotic effects of a 50% hydroalcoholic extract from the leaves and stems of J. spicigera on androgen-sensitive LNCaP prostate cancer cells. Phytochemical profiling via TLC and LC-MS putatively identified the bioactive flavonoid kaempferitrin within the complex extract. Biological assays, including MTT, trypan blue exclusion, and flow cytometry, revealed that the extract inhibits LNCaP proliferation in a distinct, dose-dependent manner. At a lower concentration (250 µg/mL), the extract exerted a primarily cytostatic effect by inducing significant G0/G1 cell cycle arrest without triggering immediate cell death. Conversely, higher concentrations (≥500 µg/mL) were potently cytotoxic, reducing cell viability to below 20% and inducing late apoptosis in approximately 58% of the population within 24 hours. These results validate the biological activity of J. spicigera in a prostate cancer model and suggest that the extract, or its constituent flavonoids could serve as a template for developing treatments that target both cell cycle checkpoints and programmed cell death.
Keywords: 
;  ;  ;  ;  ;  ;  ;  
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated